Immutep Market Capitalization from 2010 to 2025
| IMMP Stock | USD 1.90 0.02 1.06% |
Check Immutep financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immutep's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Interest Expense of 26.2 K or Selling General Administrative of 9.3 M, as well as many indicators such as Price To Sales Ratio of 80.26, Dividend Yield of 0.0 or PTB Ratio of 2.06. Immutep financial statements analysis is a perfect complement when working with Immutep Valuation or Volatility modules.
Immutep | Market Capitalization |
Latest Immutep's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Immutep Ltd ADR over the last few years. It is Immutep's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immutep's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 287.26 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Immutep Market Capitalization Regression Statistics
| Arithmetic Mean | 318,664,200 | |
| Geometric Mean | 254,555,210 | |
| Coefficient Of Variation | 64.94 | |
| Mean Deviation | 168,517,335 | |
| Median | 257,554,384 | |
| Standard Deviation | 206,951,355 | |
| Sample Variance | 42828.9T | |
| Range | 570M | |
| R-Value | (0.50) | |
| Mean Square Error | 34572.9T | |
| R-Squared | 0.25 | |
| Significance | 0.05 | |
| Slope | (21,585,159) | |
| Total Sum of Squares | 642433T |
Immutep Market Capitalization History
About Immutep Financial Statements
Immutep shareholders use historical fundamental indicators, such as Market Capitalization, to determine how well the company is positioned to perform in the future. Although Immutep investors may analyze each financial statement separately, they are all interrelated. The changes in Immutep's assets and liabilities, for example, are also reflected in the revenues and expenses on on Immutep's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. Immutep Limited was incorporated in 1987 and is headquartered in Sydney, Australia. Immutep operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Additional Tools for Immutep Stock Analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.